Investment Summary

AIkido Pharma Invests In Databricks

On May 12, 2022, AIkido Pharma invested in software company Databricks

Investment Highlights
  • This is AIkido Pharma’s 1st transaction in the Software sector.
  • This is AIkido Pharma’s 4th transaction in the United States.
  • This is AIkido Pharma’s 1st transaction in California.

Investment Summary

Date 2022-05-12
Target Databricks
Sector Software
Investor(s) AIkido Pharma
Deal Type Stake Purchase

Target

Databricks

San Francisco, California, United States
Databricks is an open-source community that helps organizations make all their data ready for analytics, empowers data science and data-driven decisions across the organization, and rapidly adopts machine learning to outpace the competition. By providing data teams with the ability to process massive amounts of data in the Cloud and power AI with that data, Databricks helps organizations innovate faster and tackle challenges like treating chronic disease through faster drug discovery, improving energy efficiency, and protecting financial markets. Databricks was founded in 2013 and is based in San Francisco, California.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

AIkido Pharma

New York, New York, United States

Category Company
Founded 1967
Sector Information Technology
Employees4
Revenue 1M USD (2017)
DESCRIPTION

AIkido Pharma is a scientific research company offers a diversified commercialization platform for protected technologies. AIkido Pharma founded was incorporated in 1967 and is based in New York, New York.


DEAL STATS #
Overall 4 of 4
Sector (Software) 1 of 1
Type (Stake Purchase) 1 of 1
State (California) 1 of 1
Country (United States) 4 of 4
Year (2022) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-11 CBM Biopharma

United States

CBM Biopharma LLC is a privately held pharmaceutical company with a team of drug development scientists provides numerous cancer treatment, including acute myeloid leukemia (AML), Acute Lymphoblastic Leukemia (ALL) and pancreatic cancer.

Buy -